Who is sponsoring TAP?

TAP is sponsored by Pacira Pharmaceuticals, Inc.

What condition does TAP study?

TAP studies Postsurgical Pain, Analgesia, Prostatectomy.

What drugs are being tested in TAP?

Interventions: EXPAREL 20 mL, EXPAREL 40 mL.

Last reviewed 2021-06-11 · How we verify

Evaluation of the Safety and Efficacy of EXPAREL When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) for Prolonged Postsurgical Analgesia in Subjects Undergoing Robot-assisted Laparoscopic Prostatectomy

NCT01582477 Phase 4 COMPLETED Results posted

The purpose of the study is to assess the safety and efficacy of EXPAREL when administered via infiltration into the transversus abdominis plane (TAP) to prolonged postsurgical analgesia in men undergoing robot-assisted laparoscopic prostatectomy.

Details

Lead sponsor	Pacira Pharmaceuticals, Inc
Phase	Phase 4
Status	COMPLETED
Enrolment	24
Start date	2012-03
Completion	2012-07

Conditions

Postsurgical Pain
Analgesia
Prostatectomy

Interventions

EXPAREL 20 mL
EXPAREL 40 mL

Primary outcomes

The Duration of Abdominal Analgesia From Infiltration Into the TAP — First postsurgical administration of an opioid

Countries

United States